is semaglutide hard on your liver – Semaglutide Liver Disease Trial Shows
Description
In a phase IV trial for 48 weeks, the effects of combined therapy with empaglifozin and semaglutide, empaglifozin monotherapy, and a placebo will be compared with 192 patients with biopsy-confirmed NASH with cirrhosis and T2DM (COMBATT2NASH, NCT04639414)
JAMA ophthalmology , 142 (8), 732-739
Mounjaro, FDA-approved for diabetes), and liraglutide (Saxenda)
Results of Clinical Trials in Terms of Efficacy and Safety Overall, the results of clinical trials on semaglutide have been positive and promising
Individuals without contraindications such as a history of thyroid cancer or severe gallbladder problems
